Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer

We report the data for the secondary end point of disease-free survival (DFS).

Source: Journal of Surgical Research - July 26, 2017 Category: Surgery Authors: Takashi Ishikawa, Kouhei Akazawa, Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, Daishu Miura, Mitsuhiro Hayashi, Norio Kohno Tags: Oncology Source Type: research